Cancer is a prominent contributor to mortality rates and a significant obstacle to improving life expectancy worldwide. Cancer is an assortment of disorders marked by various genetic and cellular abnormalities that lead to unrestrained cell proliferation, invasion and progression (
Hanahan and Weinberg, 2000). According to GLOBOCON 2020, data were obtained from 185 countries encompassing 36 different forms of malignancies and there were about 19.3 million newly diagnosed cases of cancer and 10 million deaths caused by cancer globally. In 2020, it is anticipated that Asia accounts for half of all cancer diagnoses and 58.3% of cancer-related deaths worldwide. This is significant since Asia is home to 59.5% of the global population. Europe comprises 22.8% of the overall cancer cases and 19.6% of the cancer-related fatalities, although having only 9.7% of the world’s population. America, on the other hand, provides 20.9% of the total cancer cases and 14.2% of the global cancer mortality
(Sung et al., 2021). According to projections, the number of new cancer cases is expected to reach 26 million annually by 2030, resulting in 17 million deaths from cancer each year
(Thun et al., 2010).
Although all types of cancer pose a tremendous health fatality, among them, lung cancer is a highly fatal form of cancer that has a significant impact on both rates of morbidity and mortality
(Nghakliana et al., 2021). Its high mortality and poor prognosis are due to the difficulty of early diagnosis and the high potential to invade locally and metastasise to distant organs
(Hsieh et al., 2015). Lung cancer accounted for 1.6 million deaths globally in relation to all cancer-related fatalities
(Torre et al., 2015). The A549 cell line comprises hypotriploid alveolar basal epithelial cells. The establishment of this cell line was first accomplished by
Giard et al., (1973) by the extraction and cultivation of lung carcinoma tissue from the excised tumour of a 58-year-old Caucasian man. These cells proliferate as a single layer in a laboratory setting and are often used to evaluate the anticancer effects of various plant extracts
in vitro.
(An et al., 2014; Venugopal et al., 2017; Kumar et al., 2017).
Though there are several cancer treatment options available, the overall death rate for cancer does not seem to diminish. Over the last decade, recently created synthetic chemotherapeutic medicines, which are now being used in clinical environments, have not lived up to expectations despite the substantial expenditure in their development. Therefore, there is a continuous need to develop innovative, powerful and affordable anti-cancer drugs (
Coseri, 2009). Plants and natural products remain a significant reservoir of anti-cancer substances because of their safety, effectiveness and reduced adverse effects. Since the beginning of ancient medicine, plant-derived chemical substances have been used to treat human ailments. Over the last three decades, there has been a growing interest in natural products due to their potential as innovative agents for preventing and treating cancer (
Newman, 2008;
Newman et al., 2003). There have been reports of over 3000 plants from around the world possessing properties that may be effective against cancer. On a global scale, the utilisation of plant-derived products for cancer treatment ranges from 10% to 40%, increasing to 50% among patients in Asia
(Solowey et al., 2014).
The MTT in vitro cell proliferation assay is a commonly utilised method for assessing the initial anticancer potential of both natural and synthetic derivatives (
Janice 2013). The measurement of viable cells is conducted using colourimetry, which is based on the principle of mitochondrial dehydrogenase enzymes. These enzymes produce NADH or NADPH, reducing colourless 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide salt and turning it into a visually detectable soluble formazan product. This reaction occurs due to the mitochondrial activity of viable cells at a temperature of 37°C. The amount of the coloured product is directly linked to the number of live cells in the culture. This is because the MTT reagent can only be reduced to formazan by metabolically active cells
(Pallaka et al., 2019).
Keeping all the above information in mind, the present investigation has been intended to investigate the anti-cancer properties of seven wild edible fruits,
viz.
Citrus grandis, Citrus jambhiri, Citrus medica, Morus nigra, Rubus treutleri, Artocarpus heterophyllus and
Tamarindus indica of Mizoram, India. This study may be useful to know the best wild edible fruits having anti-cancerous properties and help the pharmaceutical companies to formulate the anti-cancerous drugs by using these naturally occurring wild edible fruits.